Back
AXIM Biotechnologies Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
25
AXIM
AXIM Biotechnologies
Last Price:
0.0100
Seasonality Move:
-7.22%
Sell
20
NBY
NovaBay Pharmaceuticals
Last Price:
2.53
Seasonality Move:
0.86%
Sell
25
AXIM Biotechnologies (AXIM)
is a Sell
Is AXIM Biotechnologies a Buy, Sell or Hold?
- The current AXIM Biotechnologies [AXIM] share price is $0.0078. The Score for AXIM is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- AXIM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $2.57. The Score for NBY is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
AXIM Stock Price Chart
What is AXIM Biotechnologies's stock price today?
-
The AXIM Biotechnologies share price today is $0.0078
The current trend is relatively stagnant and AXIM is experiencing slight selling pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $2.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing selling pressure, which indicates risk of future bearish movement.
AXIM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 41.89 | Sell |
Chaikin Money Flow: | -3066 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.0093 - 0.0093) | Sell |
Bollinger Bands (100): | (0.0135 - 0.0135) | Sell |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 40.23 | Sell |
Chaikin Money Flow: | -124347 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.67 - 4.69) | Sell |
Bollinger Bands (100): | (3.1 - 5.3) | Sell |
AXIM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.01 | Sell |
20-day SMA: | 0.01 | Sell |
50-day SMA: | 0.01 | Sell |
200-day SMA: | 0.02 | Sell |
8-day EMA: | 0.01 | Sell |
20-day EMA: | 0.01 | Sell |
50-day EMA: | 0.01 | Sell |
200-day EMA: | 0.02 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.8 | Sell |
20-day SMA: | 3.84 | Sell |
50-day SMA: | 3.35 | Sell |
200-day SMA: | 8.24 | Sell |
8-day EMA: | 2.93 | Sell |
20-day EMA: | 3.33 | Sell |
50-day EMA: | 3.67 | Sell |
200-day EMA: | 15.28 | Sell |
AXIM Biotechnologies Earnings Growth & AXIM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.48 per share, an increase next quarter of $0.35 per share, an increase this year of $74.90 per share, and an increase next year of $5.60 per share.
AXIM Biotechnologies Technical Analysis
May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |